NCT04527809

Brief Summary

A double-blinded randomized controlled trial will be conducted, and all the participants will undertake one session of non-immersive VR tasks and tDCS-active or tDCS-sham. It will be a cross-sectional protocol. All protocol will have the assessment of Autonomic Nervous System, through Heart Rate Variability Analysis.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
54

participants targeted

Target at P50-P75 for not_applicable parkinson-disease

Timeline
Completed

Started Jul 2019

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 1, 2019

Completed
8 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2020

Completed
5 months until next milestone

First Submitted

Initial submission to the registry

August 2, 2020

Completed
25 days until next milestone

First Posted

Study publicly available on registry

August 27, 2020

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

November 1, 2020

Completed
Last Updated

August 27, 2020

Status Verified

August 1, 2020

Enrollment Period

8 months

First QC Date

August 2, 2020

Last Update Submit

August 25, 2020

Conditions

Outcome Measures

Primary Outcomes (1)

  • Motor skills improvement

    The motor skills will be analyzed through the games developed specifically for analysis of motor skills, such as (interception skills, speed, accuracy and reaction time).

    8 weeks.

Secondary Outcomes (1)

  • Heart Rate Variability

    8 weeks.

Study Arms (2)

tDCS-active

EXPERIMENTAL

tDCS-active will be performed over one session during the practice of VR games. The frequency of current applied will be 2mA. The stimulation intensity will be set at 100%, and the anodal electrode will be at the M1 area, and the cathodal electrode at the contralateral supraorbital area.

Device: tDCS-active

tDCS-sham

SHAM COMPARATOR

tDCS-sham will be performed over one session during the practice of VR games. The frequency of current applied will be 2mA. The stimulation intensity will be set at 100%, and the anodal electrode will be at the M1 area, and the cathodal electrode at the contralateral supraorbital area. For the TDCS-sham the same active procedure setting will be used, however, the current will be interrupted after 20 seconds. This configuration will ensure that the electrical stimulus is interrupted before generating considerable stimuli, while the other characteristics of the intervention will be maintained.

Device: tDCS-sham

Interventions

One session of active Trasncranial Direct Current Stimulation combine to a Virtual Reality task.

tDCS-active
tDCS-shamDEVICE

One session of sham Trasncranial Direct Current Stimulation combine to a Virtual Reality task.

tDCS-sham

Eligibility Criteria

Age40 Years - 90 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Parkinson's Disease with diagnosis previoulsy confirmed by a specialized doctor.
  • Agreement to participate in the research by signing the informed consent form.

You may not qualify if:

  • Wheelchair use
  • Unable to complete the procedures due to any reported fatigue.
  • Unable to complete the procedures due having to leave previously.
  • Could not stand without any kind of help, such as a carrier or walking aids.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

School of Arts, Sciences and Humanities of the University of Sao Paulo

São Paulo, São Paulo, 03828000, Brazil

Location

MeSH Terms

Conditions

Parkinson Disease

Condition Hierarchy (Ancestors)

Parkinsonian DisordersBasal Ganglia DiseasesBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesMovement DisordersSynucleinopathiesNeurodegenerative Diseases

Study Officials

  • Talita D Silva, Ph.D.

    University of Sao Paulo

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, INVESTIGATOR
Masking Details
The participants, researchers and outcome assessors will remain blind throughout the study. To ensure proper blinding, the researcher responsible for that, will configurate the code of the tDCS device to sham or active before the proper application. It will be no difference between the devices for sham or active application of the tDCS.
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: The participants will undertake a single session of non-immersive VR tasks and tDCS-active or tDCS-sham.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Researcher

Study Record Dates

First Submitted

August 2, 2020

First Posted

August 27, 2020

Study Start

July 1, 2019

Primary Completion

March 1, 2020

Study Completion

November 1, 2020

Last Updated

August 27, 2020

Record last verified: 2020-08

Data Sharing

IPD Sharing
Will not share

Locations